Delivery Order SPE2DB22D3301-SPE2DB25FX9EK
Award Date
1/29/25
Potential Completion Date
2/20/25
Potential Value
$103K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $58,213, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 200 unit vials and has a period of performance through September 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the drug Botox, with a ceiling value of $2,910.65 and a completion date of December 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,613.50 firm fixed price delivery order is for the supply of 200-unit vials of BOTOX. The contract has a completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, valued at $10,257.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 200 unit vials and has a completion date of February 11, 2025. Amerisourcebergen is the prime contractor for this award, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award, valued at $17,095.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a pharmaceutical product, with a final completion date of February 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award, valued at $1,722.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 100 unit vials, with a completion date of February 6, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $89,752.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (SPE2DB25FM3L0) under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4,566,953,249 units of BOTOX 200 UNIT VIALS to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,095.80, is a delivery order for 4,567,094,075 units of BOTOX 200 unit vials. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract was not designated with a specific set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $5,168.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of Botox medication, with a completion date of February 7, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...